Press Release: AOBiome : USPTO Grants AOBiome Therapeutics Composition of Matter Patent for its Clinical Candidate B244
B244 has demonstrated clinical efficacy on therapeutic indications including: Atopic Dermatitis (Eczema) and Pruritus (Itch), and Acne Vulgaris (Acne) CAMBRIDGE, MA, UNITED STATES, October 9, 2024 /EINPresswire.com/ -- USPTO Grants AOBiome Therapeutics ...
Read full article »
AOBiome focuses on developing skin care products that restore ammonia-oxidizing bacteria.
Read more